Chemical Name: (2S,3R,4R,5S,6R)-2-(3-((5-(4-Fluorophenyl)thiophen-2-yl)methyl)-4-(methyl-d3)phenyl-2,5,6-d3)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
Smiles: O[C@H]1[C@H](C(C([2H])=C2[2H])=C(C(CC3=CC=C(C4=CC=C(F)C=C4)S3)=C2C([2H])([2H])[2H])[2H])O[C@H](CO)[C@@H](O)[C@@H]1O
Inchi: InChI=1S/C24H25FO5S/c1-13-2-3-15(24-23(29)22(28)21(27)19(12-26)30-24)10-16(13)11-18-8-9-20(31-18)14-4-6-17(25)7-5-14/h2-10,19,21-24,26-29H,11-12H2,1H3/t19-,21-,22+,23-,24+/m1/s1/i4D,5D,6D,7D
Development and validation of HPLC method for determination of trace level potential genotoxic hydroperoxide impurity in canagliflozin
By Gosar, Amit; Shaikh, Tabrez; Botkondle, Suresh; Mahadik, Neelam; Tole, Rahul
From International Journal of Pharma Research and Health Sciences (2019), 7(5), 3068-3071
Bioanalytical method development and validation of canagliflozin in human plasma by liquid chromatography-tandem mass spectrometry
By Deepan, T.; Rao, M. V. Basaveswara; Dhanaraju, M. D.
From Asian Journal of Pharmaceutical and Clinical Research (2019), 12(8), 46-51
Analytical method development and validation of canagliflozin and metformin HCl by using RP - HPLC
By Bakshi, Anjali; Reddy, Ns; Bhutada, Shweta; Raju, M. Bhagvan
From International Journal of Pharmacy and Pharmaceutical Research (2018), 12(4), 122-130